XFOR — X4 Pharmaceuticals Inc · rev $4.8M

X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.

Latest reported XFOR revenue for 2026-06-30 was $4.8M. Net income was -$36.4M. Revenue was up 92.0% from 2026-03-31 to 2026-06-30. XFOR currently screens at market cap $382.0M.

Use this XFOR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XFOR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XFOR SEC filings page. Lician reads the product cache first so this HTML stays unique to X4 Pharmaceuticals Inc even when a live quote feed is slow.

X4 Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full XFOR income, balance, and cash tables.

  • Revenue$6.5M
  • Net Income-$79.2M
  • Total Assets$290.5M
  • Total Debt$0
  • Free Cash Flow-$85.6M

XFOR recent filings